<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<div>
<p class="MsoNormal"><span style="font-size:12.0pt">Good morning all, <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Please see below for a new funding opportunity from NACCHO.
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><span style="font-size:12.0pt"><a href="https://www.naccho.org/blog/articles/funding-announcement-2023-2024-harm-reduction-and-academic-detailing-hrad-project">New Funding Opportunity to Build Capacity in Harm Reduction
Communication: Harm Reduction & Academic Detailing (HRAD) Project</a><o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:1.0in"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><span style="font-size:12.0pt">With support from the Centers for Disease Control and Prevention (CDC), NACCHO is pleased to offer a funding opportunity for health departments or government, nonprofit, academic,
or other organizations to develop key messages on harm reduction that can be delivered through academic detailing. Through this project, selected sites will identify and develop/pilot messages for a population that would benefit from detailing on harm reduction
and overdose prevention and response and has meaningful engagement with the priority population of people who use drugs.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><span style="font-size:12.0pt">Through this funding opportunity, NACCHO and CDC will award up to eight (8) applicants, for up to $60,000 per site.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:1.0in"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><span style="font-size:12.0pt"><a href="https://www.naccho.org/blog/articles/funding-announcement-2023-2024-harm-reduction-and-academic-detailing-hrad-project">Click here</a> to learn more and apply. NACCHO is hosting
weekly office hours for interested applicants to join and ask questions about the RFP – details available in the previous link. Please reach out to
<a href="mailto:Audrey%20Eisemann%20%3cAEisemann@naccho.org%3e">Audrey Eisemann</a> and
<a href="mailto:Bailey%20McInnes%20%3cbmcinnes@naccho.org%3e">Bailey McInnes</a> from NACCHO’s Overdose, Injury, & Violence Prevention (OIVP) team if you have any questions.
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Thanks, <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Elika <o:p></o:p></span></p>
<div>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri Light",sans-serif;color:#008FC5;letter-spacing:.3pt">Elika Upadhyay</span></b>
<b><span style="color:#D14414"><br>
</span></b><span style="color:#404040">Senior Associate, Drug User Health</span><o:p></o:p></p>
<p class="MsoNormal"><span style="color:#404040">Pronouns: She/Her/Hers<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#404040">202.897.0108 (o) |</span><span style="color:#008FC5">
<a href="mailto:eupadhyay@NASTAD.org">eupadhyay@NASTAD.org</a></span><o:p></o:p></p>
<p class="MsoNormal"><span style="color:#404040">Connect with us: </span><a href="https://www.linkedin.com/company/nastad"><span style="color:#404040">LinkedIn</span></a><span style="color:#404040"> |
</span><a href="https://www.facebook.com/NASTAD"><span style="color:#404040">Facebook</span></a><span style="color:#404040"> |
</span><a href="https://twitter.com/NASTAD"><span style="color:#404040">Twitter</span></a><span style="color:#404040"> |
</span><a href="https://www.youtube.com/user/NASTAD1992"><span style="color:#404040">YouTube</span></a><span style="color:#404040"> |
</span><a href="http://www.instagram.com/nastad1992"><span style="color:#404040">Instagram</span></a><span style="color:#1F497D"><br>
</span><b><span style="color:#008FC5;letter-spacing:.3pt">NASTAD</span></b><span style="color:#008FC5">
</span><span style="color:#404040">| 444 North Capitol Street NW, Suite 339 | Washington, DC 20001|
</span><a href="http://www.nastad.org/"><span style="color:#404040">NASTAD.org</span></a><span style="color:#404040">
</span><o:p></o:p></p>
<p class="MsoNormal"><span style="font-size:8.0pt;color:#404040;letter-spacing:.3pt">This email and any files transmitted with it are confidential and intended solely for the use of the entity to whom they are addressed. If you received this email in error
please notify the sender.</span><o:p></o:p></p>
</div>
</div>
</div>
</body>
</html>